Reduced innate immune response, apoptosis, and virus release in cells cured of respiratory syncytial virus persistent infection

Virology

Volumn 410, Issue 1, 2011, Pages 56-63

  Herranz, Cristina ^a   Melero, José A ^a,b   Martínez, Isidoro ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Apoptosis; Chemokine; Innate immune response; Interleukin; Respiratory syncytial virus; RIG I; Toll like receptor; Virus persistence

Indexed keywords

RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CLONE; CELL SURVIVAL; CONTROLLED STUDY; HEP 2 CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS RELEASE;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CRICETINAE; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS RELEASE; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; RESPIRATORY SYNCYTIAL VIRUS;

EID: 78650749903     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.10.035     Document Type: Article

References (56)

1. Ahmed R., Canning W.M., Kauffman R.S., Sharpe A.H., Hallum J.V., Fields B.N. Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell 1981, 25:325-332.
2. Antoni B.A., Sabbatini P., Rabson A.B., White E. Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J. Virol. 1995, 69:2384-2392.
3. Bachi T. Direct observation of the budding and fusion of an enveloped virus by video microscopy of viable cells. J. Cell Biol. 1988, 107:1689-1695.
4. Baum A., Garcia-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids 2010, 38:1283-1299.
5. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., Colbere-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology 1992, 186:398-408.
6. Casola A., Garofalo R.P., Jamaluddin M., Vlahopoulos S., Brasier A.R. Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J. Immunol. 2000, 164:5944-5951.
7. Collins P., Crowe J. Respiratory syncytial virus and metapneumovirus. Fields Virology 2007, 1601-1646. Lippincott Williams & Wilkins, Philadelphia. Fifth ed. D. Knipe, P. Howley (Eds.).
8. Collins P.L., Graham B.S. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 2008, 82:2040-2055.
9. Crystal R.G., Randell S.H., Engelhardt J.F., Voynow J., Sunday M.E. Airway epithelial cells: current concepts and challenges. Proc. Am. Thorac. Soc. 2008, 5:772-777.
10. Chen W., Baric R.S. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J. Virol. 1996, 70:3947-3960.
11. de la Torre J.C., Martinez-Salas E., Diez J., Domingo E. Extensive cell heterogeneity during persistent infection with foot-and-mouth disease virus. J. Virol. 1989, 63:59-63.
12. de la Torre J.C., Martinez-Salas E., Diez J., Villaverde A., Gebauer F., Rocha E., Davila M., Domingo E. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J. Virol. 1988, 62:2050-2058.
13. Dermody T.S., Nibert M.L., Wetzel J.D., Tong X., Fields B.N. Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J. Virol. 1993, 67:2055-2063.
14. Garcia-Barreno B., Palomo C., Penas C., Delgado T., Perez-Brena P., Melero J.A. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J. Virol. 1989, 63:925-932.
15. Hallak L.K., Spillmann D., Collins P.L., Peeples M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 2000, 74:10508-10513.
16. Hegele R.G., Hayashi S., Bramley A.M., Hogg J.C. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest 1994, 105:1848-1854.
17. Heguy A., Harvey B.G., Leopold P.L., Dolgalev I., Raman T., Crystal R.G. Responses of the human airway epithelium transcriptome to in vivo injury. Physiol. Genomics 2007, 29:139-148.
18. Indoh T., Yokota S., Okabayashi T., Yokosawa N., Fujii N. Suppression of NF-kappaB and AP-1 activation in monocytic cells persistently infected with measles virus. Virology 2007, 361:294-303.
19. Jamaluddin M., Casola A., Garofalo R.P., Han Y., Elliott T., Ogra P.L., Brasier A.R. The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. J. Virol. 1998, 72:4849-4857.
20. Kapikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., Stewart C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 1969, 89:405-421.
21. Kaplan G., Levy A., Racaniello V.R. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J. Virol. 1989, 63:43-51.
22. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci. 2008, 1143:1-20.
23. Klein Klouwenberg P., Tan L., Werkman W., van Bleek G.M., Coenjaerts F. The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Crit. Rev. Immunol. 2009, 29:531-550.
24. Krishnan S., Halonen M., Welliver R.C. Innate immune responses in respiratory syncytial virus infections. Viral Immunol. 2004, 17:220-233.
25. Krusat T., Streckert H.J. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 1997, 142:1247-1254.
26. Labadie K., Saulnier A., Martin-Latil S., Colbere-Garapin F. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection. J. Virol. 2007, 81:3033-3036.
27. Levine S., Hamilton R. Kinetics of the respiratory syncytial virus growth cycle in HeLa cells. Arch. Gesamte Virusforsch. 1969, 28:122-132.
28. Ling Z., Tran K.C., Teng M.N. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 2009, 83:3734-3742.
29. Liu P., Jamaluddin M., Li K., Garofalo R.P., Casola A., Brasier A.R. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 2007, 81:1401-1411.
30. Lu B., Ma C.H., Brazas R., Jin H. The major phosphorylation sites of the respiratory syncytial virus phosphoprotein are dispensable for virus replication in vitro. J. Virol. 2002, 76:10776-10784.
31. Mankouri J., Dallas M.L., Hughes M.E., Griffin S.D., Macdonald A., Peers C., Harris M. Suppression of a pro-apoptotic K+ channel as a mechanism for hepatitis C virus persistence. Proc. Natl Acad. Sci. USA 2009, 106:15903-15908.
32. Martin Hernandez A.M., Carrillo E.C., Sevilla N., Domingo E. Rapid cell variation can determine the establishment of a persistent viral infection. Proc. Natl Acad. Sci. USA 1994, 91:3705-3709.
33. Martinez I., Dopazo J., Melero J.A. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J. Gen. Virol. 1997, 78(Pt 10):2419-2429.
34. Martinez I., Lombardia L., Garcia-Barreno B., Dominguez O., Melero J.A. Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J. Gen. Virol. 2007, 88:570-581.
35. Martinez I., Lombardia L., Herranz C., Garcia-Barreno B., Dominguez O., Melero J.A. Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type. Virology 2009, 388:31-41.
36. Martinez I., Melero J.A. Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J. Gen. Virol. 2000, 81:2715-2722.
37. Monick M.M., Cameron K., Staber J., Powers L.S., Yarovinsky T.O., Koland J.G., Hunninghake G.W. Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J. Biol. Chem. 2005, 280:2147-2158.
38. Mrukowicz J.Z., Wetzel J.D., Goral M.I., Fogo A.B., Wright P.F., Dermody T.S. Viruses and cells with mutations affecting viral entry are selected during persistent rotavirus infections of MA104 cells. J. Virol. 1998, 72:3088-3097.
39. O'Donnell D.R., Milligan L., Stark J.M. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology 1999, 257:198-207.
40. Oshansky C.M., Zhang W., Moore E., Tripp R.A. The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol. 2009, 4:279-297.
41. Perez-Yarza E.G., Moreno A., Lazaro P., Mejias A., Ramilo O. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr. Infect. Dis. J. 2007, 26:733-739.
42. Prince G.A., Curtis S.J., Yim K.C., Porter D.D. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J. Gen. Virol. 2001, 82:2881-2888.
43. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89:1-47.
44. Robinzon S., Dafa-Berger A., Dyer M.D., Paeper B., Proll S.C., Teal T.H., Rom S., Fishman D., Rager-Zisman B., Katze M.G. Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus. J. Virol. 2009, 83:5495-5504.
45. Ron D., Tal J. Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute virus of mice in L-cells. J. Virol. 1985, 55:424-430.
46. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 2005, 79:3350-3357.
47. Schwarze J., O'Donnell D.R., Rohwedder A., Openshaw P.J. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am. J. Respir. Crit. Care Med. 2004, 169:801-805.
48. Sikkel M.B., Quint J.K., Mallia P., Wedzicha J.A., Johnston S.L. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr. Infect. Dis. J. 2008, 27:S63-S70.
49. Spann K.M., Tran K.C., Collins P.L. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 2005, 79:5353-5362.
50. Streckert H.J., Philippou S., Riedel F. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6weeks after experimental infection and despite of the production of neutralizing antibodies. Arch. Virol. 1996, 141:401-410.
51. Swedan S., Musiyenko A., Barik S. Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J. Virol. 2009, 83:9682-9693.
52. Utley T.J., Ducharme N.A., Varthakavi V., Shepherd B.E., Santangelo P.J., Lindquist M.E., Goldenring J.R., Crowe J.E. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl Acad. Sci. USA 2008, 105:10209-10214.
53. Wilkinson T.M., Donaldson G.C., Johnston S.L., Openshaw P.J., Wedzicha J.A. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006, 173:871-876.
54. Yeo D.S., Chan R., Brown G., Ying L., Sutejo R., Aitken J., Tan B.H., Wenk M.R., Sugrue R.J. Evidence that selective changes in the lipid composition of raft-membranes occur during respiratory syncytial virus infection. Virology 2009, 386:168-182.
55. Zhang Y., Luxon B.A., Casola A., Garofalo R.P., Jamaluddin M., Brasier A.R. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 2001, 75:9044-9058.
56. Zhong J., Gastaminza P., Chung J., Stamataki Z., Isogawa M., Cheng G., McKeating J.A., Chisari F.V. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 2006, 80:11082-11093.